tiprankstipranks
Trending News
More News >
AnaptysBio (ANAB)
NASDAQ:ANAB
US Market

AnaptysBio (ANAB) Income Statement

Compare
660 Followers

AnaptysBio Income Statement

Last quarter (Q4 2025), AnaptysBio's total revenue was $108.25M, an increase of 151.08% from the same quarter last year. In Q4, AnaptysBio's net income was $49.61M. See AnaptysBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 234.60M$ 91.28M$ 17.16M$ 10.29M$ 63.17M
Gross Profit
$ 232.18M$ -72.56M$ -115.13M$ -78.51M$ -35.32M
Operating Expenses
$ 184.28M$ 42.39M$ 49.28M$ 36.64M$ 21.49M
Depreciation and Amortization
$ 2.42M$ 2.40M$ 652.00K$ 2.33M$ 2.09M
EBITDA
$ 50.32M$ -92.74M$ -156.42M$ -105.26M$ -55.71M
Operating Income
$ 47.90M$ -114.95M$ -164.41M$ -115.15M$ -56.81M
Other Income/Expenses
$ -60.96M$ -30.28M$ 788.00K$ -13.55M$ -982.00K
Pretax Income
$ -13.07M$ -145.23M$ -163.62M$ -128.70M$ -57.80M
Net Income
$ -13.23M$ -145.23M$ -163.62M$ -128.72M$ -57.80M
Per Share Metrics
Basic EPS
$ -0.46$ -5.12$ -6.08$ -4.57$ -2.11
Diluted EPS
$ -0.46$ -5.12$ -6.08$ -4.57$ -2.11
Weighted Average Shares Outstanding
27.79M 28.38M 26.92M 28.16M 27.43M
Weighted Average Shares Outstanding (Diluted)
31.34M 28.38M 26.92M 28.16M 27.43M
Currency in USD

AnaptysBio Earnings and Revenue History